Authors: SMITH LJ HANBY LA LAVINS BJ SIMONSON SG

Citation: Lj. Smith et al., A SINGLE-DOSE OF ZAFIRLUKAST REDUCES LTD4-INDUCED BRONCHOCONSTRICTIONIN PATIENTS ON MAINTENANCE INHALED CORTICOSTEROID-THERAPY, Annals of allergy, asthma, & immunology, 81(1), 1998, pp. 43-49

Authors: CALHOUN WJ LAVINS BJ MINKWITZ MC EVANS R GLEICH GJ COHN J

Citation: Wj. Calhoun et al., EFFECT OF ZAFIRLUKAST (ACCOLATE) ON CELLULAR MEDIATORS OF INFLAMMATION - BRONCHOALVEOLAR LAVAGE FLUID FINDINGS AFTER SEGMENTAL ANTIGEN CHALLENGE, American journal of respiratory and critical care medicine, 157(5), 1998, pp. 1381-1389

Authors: LAZARUS SC WONG HH WATTS MJ BOUSHEY HA LAVINS BJ MINKWITZ MC

Citation: Sc. Lazarus et al., THE LEUKOTRIENE RECEPTOR ANTAGONIST ZAFIRLUKAST INHIBITS SULFUR DIOXIDE-INDUCED BRONCHOCONSTRICTION IN PATIENTS WITH ASTHMA, American journal of respiratory and critical care medicine, 156(6), 1997, pp. 1725-1730

Authors: ROSENTHAL R LAVINS BJ HANBY LA

Citation: R. Rosenthal et al., EFFECT OF TREATMENT WITH ZAFIRLUKAST (ACCOLATE(TM)) ON BRONCHIAL HYPERRESPONSIVENESS IN PATIENTS WITH MILD-TO-MODERATE ASTHMA, Journal of allergy and clinical immunology, 97(1), 1996, pp. 270-270

Authors: LOCKEY RF LAVINS BJ SNADER L

Citation: Rf. Lockey et al., EFFECTS OF 13 WEEKS OF TREATMENT WITH ICI-204,219 (ACCOLATE(TM)) IN PATIENTS WITH MILD-TO-MODERATE ASTHMA, Journal of allergy and clinical immunology, 95(1), 1995, pp. 350-350